Last updated: May 5, 2022
Sponsor: Insight Lifetech Co., Ltd.
Overall Status: Completed
Phase
N/A
Condition
Heart Disease
Hypercholesterolemia
Chest Pain
Treatment
N/AClinical Study ID
NCT04739657
CTP-02-001
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age: 18 Years and older;
- Understand and willing to sign the informed consent form;
- Clinical evaluation shows that the coronary artery stent implantation and theintravascular ultrasound(IVUS) guidance is required.
Exclusion
Exclusion Criteria:
- Unable to understand or unwilling to sign the informed consent form;
- Clinically diagnosed with severe coronary artery spasms;
- Contraindicated to percutaneous coronary intervention (PCI);
- Presence of any other factor that the investigator deems is unsuitable for enrollmentor completion of this study.
Study Design
Total Participants: 130
Study Start date:
March 01, 2021
Estimated Completion Date:
April 27, 2021
Study Description
Connect with a study center
The General Hospital of the People's Liberation Army
Beijing,
ChinaSite Not Available
Guangdong Provincial People's Hospital
Guangzhou,
ChinaSite Not Available
Zhongda Hospital of Southeast University
Nanjing,
ChinaSite Not Available
Shanghai Tenth People's Hospital
Shanghai,
ChinaSite Not Available
Shanghai Zhongshan Hospital
Shanhai,
ChinaSite Not Available
The First Affiliated Hospital of Zhengzhou University
Zhengzhou,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.